SLKDT intervention significantly inhibited obesity‐induced inflammation by decreasing the proinflammatory factors IL‐6, TNF‐α, IFN‐γ, and IL‐1β and increasing the anti‐inflammatory cytokines IL‐4 and IL‐10. This evidence concerns the gene IL10 and Obesity.